Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: Results from a One-Year Study in Type 2 Diabetes.

Dániel, Eszter et al.·International journal of molecular sciences·2025·
RPEP-107992025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: Results from a One-Year Study in Type 2 Diabetes.
Published In:
International journal of molecular sciences, 26(21) (2025)
Database ID:
RPEP-10799

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-10799·https://rethinkpeptides.com/research/RPEP-10799

APA

Dániel, Eszter; Sztanek, Ferenc; Csiha, Sára; Ratku, Balázs; Somodi, Sándor; Paragh, György; Harangi, Mariann; Lőrincz, Hajnalka. (2025). Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: Results from a One-Year Study in Type 2 Diabetes.. International journal of molecular sciences, 26(21). https://doi.org/10.3390/ijms262110404

MLA

Dániel, Eszter, et al. "Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: Results from a One-Year Study in Type 2 Diabetes.." International journal of molecular sciences, 2025. https://doi.org/10.3390/ijms262110404

RethinkPeptides

RethinkPeptides Research Database. "Long-Term Effects of Semaglutide and Sitagliptin on Circulat..." RPEP-10799. Retrieved from https://rethinkpeptides.com/research/daniel-2025-longterm-effects-of-semaglutide

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.